Applied Genetic Technologies Corp (NASDAQ:AGTC) is moving up slightly higher in pre-market trading. It is adding to the gains from the last 2 sessions.
Pre Market Action
As of 8:01, AGTC is trading at $3.88 up .040, gaining 1.04%. So far more than 1.6K shares have exchanged hands.
AGTC released Earnings Late Monday
AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2021
- There was no revenue for the three and nine months ended March 31, 2021. There was no revenue in the three months ended March 31, 2020 and $2.5 million of revenue in the nine months ended March 31, 2020.
- The Company’s net loss for the three and nine months ended March 31, 2021 was $14.9 million and $45.7 million, respectively, compared to $11.2 million and $31.4 million, respectively, during the comparable 2020 periods.
- As of March 31, 2021, the Company’s cash, cash equivalents and investments totaled $111.0 million.
- Research and development expenses for the three and nine months ended March 31, 2021 were $11.0 million and $34.4 million, respectively, compared to $8.3 million and $25.3 million, respectively, during the comparable 2020 periods.
“Bill has been instrumental in leading our finance team through multiple rounds of financings, enabling us to advance our best-in-class clinical and preclinical programs,” said Ms. Washer. “On behalf of the Company, I wish Bill continued success and thank him for his many contributions to AGTC.”